Our study supposes that LILRB4 may play a crucial role in modulating PD clinical characteristics by influencing nigrostriatal dopaminergic neuron function, Alzheimer's disease (AD)‐related pathology, WM microstructural alterations, and astrocyte activation. Here, LILRB4 is linked to Alzheimer disease.